Kassaflöde Zealand Pharma A/S

Aktier

ZEAL

DK0060257814

Bioteknik och medicinsk forskning

Realtidsuppskattning Cboe Europe Andra börsplatser 09:28:37 17.02.2025			5-dagars förändring	Förändring 1 jan.
764,75 ^DKK	+1,56 %		+5,70 %	+7,62 %

29.01.	SEB sänker Zealand Pharma till behåll (köp), riktkurs 800 danska kronor - BN	FW
24.01.	Novo Nordisk stiger på positiva resultat för amycretin - viktminskning på 22 procent (uppdatering)	FW

f1.gZCCfQ5SA293ET4sugEYjBq_BSOs0X9uvAfmEKuymno.6KXYH0EneSA2R1R1g2xf51j5Yxb4pzUdizGKRMbWwk7I1cRMWH9WWAJ-bw

Publicerade finansiella data: ZEALAND PHARMA A/S

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2019	2020	2021	2022	2023
Revenues	41,33 mn	353 mn	293 mn	104 mn	343 mn
Total Revenues	41,33 mn	353 mn	293 mn	104 mn	343 mn
Cost of Goods Sold, Total	415 tn	90,56 mn	119 mn	-	688 mn
Gross Profit	40,92 mn	263 mn	174 mn	104 mn	−345 mn
Selling General & Admin Expenses, Total	67,88 mn	468 mn	636 mn	270 mn	216 mn
Stock-Based Compensation (IS)	-	-	-	−11,24 mn	-
R&D Expenses	561 mn	604 mn	588 mn	612 mn	-
Other Operating Expenses	−444 tn	−602 tn	−759 tn	48,27 mn	-
Other Operating Expenses, Total	629 mn	1,07 md	1,22 md	918 mn	216 mn
Operating Income	−588 mn	−809 mn	−1,05 md	−814 mn	−561 mn
Interest Expense, Total	−3,2 mn	−2,9 mn	−4,09 mn	−57,79 mn	−25,83 mn
Interest And Investment Income	6,29 mn	1,09 mn	44 tn	6,54 mn	45,32 mn
Net Interest Expenses	3,09 mn	−1,81 mn	−4,05 mn	−51,25 mn	19,49 mn
Currency Exchange Gains (Loss)	5,52 mn	−39,49 mn	39,32 mn	25,6 mn	−9,71 mn
Other Non Operating Income (Expenses)	−185 tn	−4,83 mn	−3,47 mn	11,01 mn	−1,99 mn
EBT, Excl. Unusual Items	−580 mn	−855 mn	−1,02 md	−829 mn	−553 mn
Restructuring Charges	-	-	-	−19,1 mn	-
Merger & Related Restructuring Charges	-	−7,1 mn	-	-	-
Gain (Loss) On Sale Of Investments	2,85 mn	−1,17 mn	−6,36 mn	2,34 mn	−8,84 mn
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	−12,74 mn	−2,17 mn	−3,99 mn	−11 mn
Other Unusual Items	-	36,4 mn	-	−123 mn	−136 mn
EBT, Incl. Unusual Items	−577 mn	−840 mn	−1,03 md	−972 mn	−709 mn
Income Tax Expense	−5,14 mn	7,08 mn	−8,79 mn	−6,43 mn	−5,13 mn
Earnings From Continuing Operations	−572 mn	−847 mn	−1,02 md	−966 mn	−704 mn
Earnings Of Discontinued Operations	-	-	-	−237 mn	-
Net Income to Company	−572 mn	−847 mn	−1,02 md	−1,2 md	−704 mn
Net Income - (IS)	−572 mn	−847 mn	−1,02 md	−1,2 md	−704 mn
Net Income to Common Incl Extra Items	−572 mn	−847 mn	−1,02 md	−1,2 md	−704 mn
Net Income to Common Excl. Extra Items	−572 mn	−847 mn	−1,02 md	−966 mn	−704 mn
Per aktie poster
Net EPS - Basic	−16,91	−22,07	−23,75	−26,02	−12,44
Basic EPS - Continuing Operations	−16,91	−22,07	−23,75	−20,9	−12,44
Basic Weighted Average Shares Outstanding	33,8 mn	38,37 mn	42,87 mn	46,2 mn	56,59 mn
Net EPS - Diluted	−16,91	−22,07	−23,75	−26,02	−12,44
Diluted EPS - Continuing Operations	−16,91	−22,07	−23,75	−20,9	−12,44
Diluted Weighted Average Shares Outstanding	33,8 mn	38,37 mn	42,87 mn	46,2 mn	56,59 mn
Normalized Basic EPS	−10,72	−13,93	−14,85	−11,21	−6,11
Normalized Diluted EPS	−10,72	−13,93	−14,85	−11,21	−6,11
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Kompletterande punkter
EBITDA	−583 mn	−792 mn	−1,02 md	−727 mn	−555 mn
EBITA	−588 mn	−802 mn	−1,04 md	−814 mn	−561 mn
EBIT	−588 mn	−809 mn	−1,05 md	−814 mn	−561 mn
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	0,89	−0,84	0,86	0,66	0,72
Normalized Net Income	−362 mn	−534 mn	−637 mn	−518 mn	−346 mn
Interest on Long-Term Debt	3,39 mn	7,72 mn	7,56 mn	57,79 mn	28,98 mn
Kompletterande driftskostnadsposter
Selling and Marketing Expenses	-	273 mn	375 mn	32,3 mn	30,63 mn
General and Administrative Expenses	67,88 mn	196 mn	261 mn	237 mn	185 mn
Research And Development Expense From Footnotes	561 mn	604 mn	588 mn	614 mn	685 mn
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., COGS (Total)	-	-	521 tn	-	29,76 mn
Stock-Based Comp., R&D Exp. (Total)	12,19 mn	14 mn	22,16 mn	33,84 mn	-
Stock-Based Comp., S&M Exp. (Total)	-	6,04 mn	2,26 mn	649 tn	1,73 mn
Stock-Based Comp., G&A Exp. (Total)	2,57 mn	10,44 mn	27,97 mn	31,7 mn	29,94 mn
Stock-Based Comp., Other (Total)	-	-	-	−11,24 mn	-
Total Stock-Based Compensation	14,76 mn	30,48 mn	52,91 mn	54,94 mn	61,43 mn

Skatteperiod: December	2019	2020	2021	2022	2023
TILLGÅNGAR
Cash And Equivalents	1,08 md	960 mn	1,13 md	1,07 md	449 mn
Short Term Investments	299 mn	297 mn	-	-	-
Trading Asset Securities, Total	-	-	299 mn	109 mn	1,18 md
Total Cash And Short Term Investments	1,38 md	1,26 md	1,43 md	1,18 md	1,63 md
Accounts Receivable, Total	751 tn	46,48 mn	73,02 mn	116 mn	122 mn
Other Receivables	15,04 mn	15,44 mn	37,36 mn	21,6 mn	16,44 mn
Total Receivables	15,79 mn	61,93 mn	110 mn	137 mn	139 mn
Inventory	-	65,04 mn	118 mn	1,29 mn	7,94 mn
Prepaid Expenses	30,76 mn	35,16 mn	64,63 mn	-	-
Restricted Cash	-	-	-	-	-
Total Current Assets	1,43 md	1,42 md	1,72 md	1,32 md	1,78 md
Gross Property Plant And Equipment	192 mn	138 mn	290 mn	237 mn	220 mn
Accumulated Depreciation	−66,54 mn	−53,26 mn	−68,89 mn	−71,36 mn	−70,43 mn
Net Property Plant And Equipment	125 mn	213 mn	221 mn	165 mn	150 mn
Long-term Investments	35,63 mn	32,33 mn	26,91 mn	37,84 mn	21,38 mn
Other Intangibles, Total	2,48 mn	57,48 mn	53,79 mn	-	12,26 mn
Accounts Receivable Long-Term	-	-	-	18,1 mn	15,79 mn
Deferred Tax Assets Long-Term	-	8,37 mn	13,52 mn	2,02 mn	925 tn
Other Long-Term Assets, Total	9,01 mn	31,04 mn	30,36 mn	-	-
Total Assets	1,6 md	1,76 md	2,07 md	1,54 md	1,98 md
Skulder
Accounts Payable, Total	57,53 mn	70,38 mn	64,56 mn	181 mn	91,61 mn
Accrued Expenses, Total	43,1 mn	36,43 mn	28,7 mn	-	85,2 mn
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	7,69 mn	14,07 mn	14,9 mn	14,73 mn	16,66 mn
Current Income Taxes Payable	614 tn	30,39 mn	-	-	-
Unearned Revenue Current, Total	56,25 mn	53,18 mn	53,03 mn	-	-
Other Current Liabilities	29,95 mn	151 mn	173 mn	-	91,12 mn
Total Current Liabilities	195 mn	355 mn	334 mn	195 mn	285 mn
Long-Term Debt	-	-	648 mn	401 mn	-
Long-Term Leases	78,07 mn	116 mn	125 mn	108 mn	103 mn
Unearned Revenue Non Current	83,64 mn	44,59 mn	14,55 mn	-	-
Other Non Current Liabilities	-	16,74 mn	18,43 mn	19,06 mn	-
Total Liabilities	357 mn	533 mn	1,14 md	724 mn	387 mn
Common Stock, Total	36,06 mn	39,8 mn	43,63 mn	51,7 mn	58,75 mn
Additional Paid In Capital	2,65 md	3,47 md	4,25 md	-	6,41 md
Retained Earnings	−1,44 md	−2,29 md	−3,31 md	-	−4,89 md
Treasury Stock	-	-	−71,89 mn	-	-
Comprehensive Income and Other	-	8,98 mn	14,16 mn	764 mn	22,7 mn
Total Common Equity	1,24 md	1,23 md	928 mn	816 mn	1,59 md
Total Equity	1,24 md	1,23 md	928 mn	816 mn	1,59 md
Total Liabilities And Equity	1,6 md	1,76 md	2,07 md	1,54 md	1,98 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	35,99 mn	39,55 mn	43,22 mn	51,47 mn	58,38 mn
ECS Total Common Shares Outstanding	35,99 mn	39,74 mn	43,22 mn	51,47 mn	58,38 mn
Book Value / Share	34,53	30,94	21,47	15,85	27,28
Tangible Book Value	1,24 md	1,17 md	874 mn	816 mn	1,58 md
Tangible Book Value Per Share	34,46	29,49	20,22	15,85	27,07
Total Debt	85,76 mn	130 mn	787 mn	524 mn	119 mn
Net Debt	−1,29 md	−1,13 md	−641 mn	−654 mn	−1,51 md
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	3	5	5	5
Inventories - Raw Materials, Total	-	14,4 mn	35,82 mn	1,29 mn	7,94 mn
Inventories - Work In Process, Total	-	13,72 mn	29,59 mn	-	-
Inventories - Finished Goods, Total	-	36,92 mn	53,03 mn	-	-
Buildings, Total	-	34,1 mn	36,6 mn	-	-
Machinery, Total	69,65 mn	101 mn	107 mn	82,82 mn	78,57 mn
Full Time Employees	179	329	355	196	253

Skatteperiod: December	2019	2020	2021	2022	2023
Net Income	−572 mn	−847 mn	−1,02 md	−1,2 md	−704 mn
Depreciation & Amortization - CF	13,68 mn	23,1 mn	32,39 mn	102 mn	20,12 mn
Amortization of Goodwill and Intangible Assets - (CF)	-	6,86 mn	7,86 mn	-	-
Depreciation & Amortization, Total	13,68 mn	29,96 mn	40,25 mn	102 mn	20,12 mn
Amortization of Deferred Charges, Total - (CF)	-	-	-	1,34 mn	1,2 mn
(Gain) Loss From Sale Of Asset	-	-	2,7 mn	-	-
Asset Writedown & Restructuring Costs	-	12,74 mn	6,52 mn	−1,06 mn	4,71 mn
Stock-Based Compensation (CF)	14,76 mn	30,48 mn	53,5 mn	52,58 mn	61,43 mn
Net Cash From Discontinued Operations	-	-	-	13,5 mn	-
Other Operating Activities, Total	123 mn	−12,98 mn	−130 mn	81,38 mn	139 mn
Change In Accounts Receivable	−21,06 mn	−7,72 mn	−64,49 mn	18,22 mn	−6,76 mn
Change In Inventories	-	−14,4 mn	−52,77 mn	50,69 mn	9,34 mn
Change In Accounts Payable	17,06 mn	120 mn	−49,06 mn	−58,65 mn	39,84 mn
Change in Other Net Operating Assets	14,87 mn	-	-	-	9,68 mn
Cash from Operations	−409 mn	−689 mn	−1,21 md	−942 mn	−426 mn
Capital Expenditure	−21,04 mn	−25,04 mn	−22,13 mn	−11,71 mn	−11,24 mn
Sale of Property, Plant, and Equipment	25 tn	-	-	-	-
Cash Acquisitions	-	−168 mn	-	-	-
Sale (Purchase) of Intangible assets	−2,48 mn	-	-	-	−12,51 mn
Investment in Marketable and Equity Securities, Total	−22,8 mn	-	-	187 mn	−1,07 md
Other Investing Activities, Total	−5,37 mn	−3,97 mn	4,01 mn	106 mn	-
Cash from Investing	−51,67 mn	−197 mn	−18,12 mn	281 mn	−1,09 md
Long-Term Debt Issued, Total	-	-	648 mn	-	-
Total Debt Issued	-	-	648 mn	-	-
Long-Term Debt Repaid, Total	−8,69 mn	−29,22 mn	−14,72 mn	−450 mn	−543 mn
Total Debt Repaid	−8,69 mn	−29,22 mn	−14,72 mn	−450 mn	−543 mn
Issuance of Common Stock	698 mn	833 mn	775 mn	1,08 md	1,56 md
Repurchase of Common Stock	-	-	−28,59 mn	-	−41,6 mn
Other Financing Activities, Total	−14,44 mn	−42,71 mn	−46,9 mn	−47,46 mn	−71,91 mn
Cash from Financing	674 mn	761 mn	1,33 md	587 mn	907 mn
Foreign Exchange Rate Adjustments	7,07 mn	3,74 mn	66,22 mn	13,68 mn	−7,24 mn
Net Change in Cash	220 mn	−121 mn	169 mn	−59,87 mn	−620 mn
Kompletterande punkter
Cash Interest Paid	3,2 mn	2,9 mn	3,3 mn	34,41 mn	25,25 mn
Cash Income Tax Paid (Refund)	−93 tn	-	41,63 mn	−9,28 mn	−11,3 mn
Levered Free Cash Flow	−318 mn	−434 mn	−741 mn	−382 mn	−229 mn
Unlevered Free Cash Flow	−316 mn	−432 mn	−738 mn	−347 mn	−214 mn
Change In Net Working Capital	−46,96 mn	−38,17 mn	153 mn	−16,29 mn	−78,94 mn
Net Debt Issued / Repaid	−8,69 mn	−29,22 mn	633 mn	−450 mn	−543 mn

Skatteperiod: December	2019	2020	2021	2022	2023
Lönsamhet
Return on Assets	−25,98	−30,08	−34,28	−28,21	−19,93
Return on Total Capital	−30,06	−37,62	−42,7	−33,31	−22,99
Return On Equity %	−48,46	−68,51	−94,4	−110,75	−58,43
Return on Common Equity	−48,46	−68,51	−94,4	−110,75	−58,43
Marginalanalys
Gross Profit Margin %	99	74,37	59,39	100	−100,74
SG&A Margin	164,23	132,51	217,47	259,18	62,99
EBITDA Margin %	−1,41 tn	−224,3	−350,07	−698,78	−161,83
EBITA Margin %	−1,42 tn	−227,01	−356,27	−782,86	−163,73
EBIT Margin %	−1,42 tn	−228,95	−358,96	−782,86	−163,73
Income From Continuing Operations Margin %	−1,38 tn	−239,65	−348,01	−928,6	−205,3
Net Income Margin %	−1,38 tn	−239,65	−348,01	−1,16 tn	−205,3
Net Avail. For Common Margin %	−1,38 tn	−239,65	−348,01	−928,6	−205,3
Normalized Net Income Margin	−876,3	−151,25	−217,56	−498,09	−100,91
Levered Free Cash Flow Margin	−768,33	−122,79	−253,28	−367,48	−66,8
Unlevered Free Cash Flow Margin	−763,49	−122,27	−252,4	−334,03	−62,37
Tillgångsomslutning
Asset Turnover	0,03	0,21	0,15	0,06	0,19
Fixed Assets Turnover	0,59	2,09	1,35	0,54	2,17
Receivables Turnover (Average Receivables)	20,54	14,96	4,9	0,77	2,88
Inventory Turnover (Average Inventory)	-	-	1,3	-	149,25
Kortfristig likviditet
Current Ratio	7,31	4	5,15	6,73	6,25
Quick Ratio	7,16	3,71	4,6	6,73	6,23
Operating Cash Flow to Current Liabilities	−2,1	−1,94	−3,63	−4,82	−1,5
Days Sales Outstanding (Average Receivables)	17,77	24,47	74,55	472,24	126,7
Days Outstanding Inventory (Average Inventory)	-	-	281,82	-	2,45
Average Days Payable Outstanding	39,66 tn	-	143	-	71,55
Cash Conversion Cycle (Average Days)	-	-	213,37	-	57,6
Långsiktig solvens
Total Debt/Equity	6,9	10,58	84,87	64,23	7,49
Total Debt / Total Capital	6,46	9,57	45,91	39,11	6,96
LT Debt/Equity	6,28	9,44	83,26	62,43	6,44
Long-Term Debt / Total Capital	5,88	8,54	45,04	38,01	5,99
Total Liabilities / Total Assets	22,31	30,23	55,13	47,01	19,55
EBIT / Interest Expense	−183,45	−279,42	−256,71	−14,09	−21,73
EBITDA / Interest Expense	−179,18	−269,07	−246,87	−12,32	−20,95
(EBITDA - Capex) / Interest Expense	−185,74	−277,72	−252,28	−12,53	−21,38
Total Debt / EBITDA	−0,15	−0,17	−0,78	−0,74	−0,22
Net Debt / EBITDA	2,25	1,45	0,63	0,92	2,8
Total Debt / (EBITDA - Capex)	−0,14	−0,16	−0,76	−0,72	−0,22
Net Debt / (EBITDA - Capex)	2,17	1,4	0,62	0,9	2,74
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	8,84	754,8	−17,19	−4,2	229,65
Gross Profit, 1 Yr. Growth %	18,19	542,14	−33,87	6,57	−32,3
EBITDA, 1 Yr. Growth %